Guideline Panel Meeting: Incontinence After Prostate Treatment (2018)

October 13, 2018 to October 14, 2018

The Incontinence after Prostate Treatment Guideline panel will be meeting to develop the statements and guideline to be released at the Annual Meeting in 2019.

Target Audience

  • Urologists

Learning Objectives

After particpating in this activity, participants will be able to: 

  • Expand and update urology knowledge base
  • Analyze clinical skills and patient care methods towards improving their quality
  • Identify methods to improve teaching skills from familiarity with the most recent information and its clinical application
  • Demonstrate written communication skills from exposure to peer review of written materials
  • Implement improved critical thinking skills
Course summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Non-Physician Participation
Course opens: 
10/13/2018
Course expires: 
10/14/2021
Event starts: 
10/13/2018 - 7:30am
Event ends: 
10/14/2018 - 11:59pm
Rating: 
0

Day 1

7:30am                 Breakfast

8:00am                 Welcome & Introductions                                                                            Abid Khan

8:10am                 Conflict of Interest Disclosures and Panel Responsibilities                    Nenellia Bronson

                                CME

8:30am                 Guidelines Stages Overview                                                                        Nenellia Bronson

8:45am                 Categorizing Guidelines Statements                                                          Nenellia Bronson

9:15am                 Evidence Report Overview                                                                          Dr. Hassan Murad                           

10:00am               Evidence Report Discussion/Statement Development                           Panel

10:30am               Break (10 min)                                                                  

12:30pm               Lunch

1:00pm                 Guideline Statement Development                                                           Panel

2:45pm                 Break (10 min)

4:30pm                 Recap and Day 2 Agenda                                                                              Panel

4:45pm                 Shuttle Departs AUA to hotel                                                      

6:00pm                 Shuttle departs from hotel to dinner

Day 2

8:00am                 Breakfast

8:30am                 Drafting Guideline Statements CONT’D                                                  Panel

10:30am               Break (10 min)

11:45am               Discussion of Diagnostic/ Treatment Algorithm                                   Panel

12:15pm               Next Steps                                                                                                   Nenellia Bronson

12:30pm               Meeting Adjourned

AUA Headquarters
Linthicum, MD 21090
United States

Faculty & Planner Disclosures

Name CompanyRoleFinancial
Jaspreet Sandhu, MDGuideline Panel ChairBoston ScientificConsultant or AdvisorYes
Victor Nitti, MDChair, Office of EducationAstellasHealth Publishing, Scientific Study or TrialNo
  AllerganHealth Publishing, Scientific Study or TrialNo
  Serenity PharmeuticalsInvestment InterestYes
  MedtronicScientific Study or TrialNo
Michael Abern, MDChair, COI Review Work GroupDept. of Defense Prostate Cancer Research ProgramScientific study or Trial, Consultant or AdvisorYes
Nenellia BronsonAUA StaffNothing to disclose  

Panel Member Disclosures

IPT Guideline Panel COI Disclosures 10.05.pdf

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 11.0  AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 CreditTM.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Work Group or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA PARTICIPANT INFORMATION & POLICIES

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Non-Physician Participation

Accreditation Period

Course opens: 
10/13/2018
Course expires: 
10/14/2021
Please login or register to take this course.

This activity is restricted to members of the Incontinence after Prostate Treatment Guideline Panel.